Healthcare News Options
Novo CEO pressed by Senate to chop costs of being overweight, diabetes medications CEO Lars Fruergaard Jørgensen told lawmakers the business would take into consideration new talks with insurers concerning the listing costs of Wegovy and copyright should they pledge to keep the medicines on their own formularies.Elevance lowers steerage on ‘unpa